Neoteny, Williams Syndrome, Chromosome 7, and COVID-19: What Connects Them?

21 min read

How are neoteny, Williams syndrome, chromosome 7, and COVID-19 connected? An overview of evolutionary, genetic, and immunological links.

# Neoteny, Williams Syndrome, Chromosome 7 and COVID-19: What Connects Them?

Introduction

Few pairings in modern biology sound as improbable as neoteny, Williams syndrome, chromosome 7 and COVID-19. The first belongs to evolutionary developmental biology, the second to clinical genetics, the third to cytogenetics, and the fourth to infectious disease and immunology. Yet all four converge on a single question that has become unusually urgent since 2020: how does the architecture of the human body—shaped over millions of years of evolution, perturbed by discrete genetic deletions, and exposed to a novel respiratory virus—determine who gets sick, how sick they become, and how they recover?

This article does not claim that there is a single, well-established pathway running from neoteny through Williams syndrome and chromosome 7 to COVID-19 severity. It does not. What it does claim is that the four topics share enough molecular, developmental and epidemiological ground that placing them side by side illuminates something important about human vulnerability to SARS-CoV-2. Neoteny reminds us that the human body is not a finished, optimised machine but a developmental process frozen mid-stride. Williams syndrome shows what happens when a small slice of chromosome 7 is removed from that process. Chromosome 7 carries genes that govern elasticity, transcription and immune signalling—properties that matter enormously in a disease whose worst outcomes are vascular, inflammatory and respiratory. And COVID-19, by selecting brutally on those properties, has revealed which parts of our biology are load-bearing.

The article is structured as a tour through these four domains, followed by an honest assessment of where the connections are solid, where they are speculative, and where they are simply unknown.

Neoteny: Keeping the Juvenile in the Adult

Neoteny—also called juvenilisation—is the slowing or delaying of somatic development so that adult organisms retain traits that were juvenile in their ancestors. The word comes from the Greek néos (young) and teínein (to stretch), and it names one of the most consequential processes in vertebrate evolution. In salamanders such as the axolotl, neoteny is extreme: the adult keeps gills, a finned tail and an aquatic lifestyle. In humans, neoteny is more subtle but arguably more important, because it underlies much of what makes us human.

Compared with our closest relatives, chimpanzees and bonobos, adult humans retain a suite of juvenile features: a large, globular cranium; a flat, vertical face with a small nose and reduced brow ridge; large eyes relative to face size; small jaws and teeth; hairlessness of the body; and limbs that are proportionately short. These are not merely cosmetic. A large cranium accommodates a large brain. A flat face and small jaw reconfigure the airway and the vocal tract, enabling the complex speech that underwrites language. Reduced brow ridges and larger eyes support the fine-grained emotional signalling on which human social life depends. In other words, neoteny is not a quirk; it is a major engine of human cognitive and social evolution.

The mechanisms behind human neoteny are still debated, but they clearly involve changes in the timing and rate of gene expression during development—heterochrony. Genes that promote skeletal maturation, dental eruption or cranial suture closure appear to be expressed later or more weakly in humans than in other primates. Thyroid hormone signalling, growth hormone pathways and the insulin-like growth factor axis have all been implicated. The result is a body plan that matures slowly: humans have an exceptionally long childhood, a delayed puberty and a prolonged period of brain plasticity. That slowness is costly—it demands years of parental investment—but it buys an unmatched capacity for learning, culture and social coordination.

Neoteny also has a darker side. Because it works by delaying or softening developmental programmes, it can leave structures incompletely specialised. The human jaw is smaller than that of our ancestors, which is why wisdom teeth so often fail to erupt. The human spine, built on a quadrupedal blueprint and then reoriented for bipedalism, is prone to lower-back pain. The human airway, with its descended larynx, is a compromise between breathing and swallowing that makes us uniquely susceptible to choking. In short, neoteny gives us our strengths by relaxing constraints that other species enforce more strictly—and every relaxation is a potential point of failure.

This matters for disease. A body that is still, in some respects, developmentally unfinished is a body whose repair systems, connective tissues and immune calibration are tuned to a particular—and in evolutionary terms very recent—configuration. When a novel pathogen arrives, the places where development was relaxed are often the places where the damage concentrates.

The Genetic and Hormonal Machinery of Neoteny

Neoteny is not a vague evolutionary slogan; it is a measurable shift in developmental timing, and it has a molecular basis. In vertebrates, the pace of maturation is governed by a network of signalling systems that can be accelerated or delayed without changing the underlying body plan. Thyroid hormone is the most studied of these: in amphibians, a surge of thyroid hormone triggers metamorphosis, and blocking it produces a permanently larval, neotenous adult. In mammals, thyroid hormone modulates skeletal maturation, dental eruption and brain development, and variations in thyroid signalling have been proposed as one of the mechanisms behind the prolonged human childhood.

Growth hormone and the insulin-like growth factor 1 (IGF-1) axis are equally important. IGF-1 promotes bone growth, tissue repair and metabolic maturation; lower or more prolonged IGF-1 signalling delays skeletal closure and extends the growth period. In humans, IGF-1 levels rise through childhood and peak in adolescence, but the timing and amplitude of that peak vary enormously between individuals and populations. A slower IGF-1 trajectory means a longer window of plasticity—and, potentially, a longer window of vulnerability to anything that disrupts development.

At the genetic level, neoteny is thought to arise from changes in the regulation of developmental genes rather than from changes in the genes themselves. Comparative genomics between humans and chimpanzees has identified differences in the expression of genes involved in bone morphogenetic protein (BMP) signalling, fibroblast growth factor (FGF) signalling and Wnt signalling—all pathways that control the rate at which tissues differentiate and mature. Human-specific changes in regulatory regions, including enhancers and non-coding RNAs, appear to delay the expression of genes that promote skeletal and dental maturation. The result is a body that follows the same developmental sequence as other primates but traverses it more slowly, and stops at a point that, in a chimpanzee, would be considered juvenile.

This regulatory delay has a cost. Genes that are expressed later or more weakly are genes whose products are present in lower amounts during the periods when they are most needed. Elastin, collagen, and other structural proteins of the extracellular matrix are among those whose expression windows are shifted. The connective tissue of a neotenous body is not defective, but it is calibrated to a different timeline—and that calibration is one reason why the human body is more susceptible to certain connective tissue disorders, joint problems and vascular fragilities than the bodies of more rapidly maturing primates.

Neoteny as a Source of Vulnerability: The Threats

The word "threat" is not too strong. Neoteny is not a disease, but it is a standing source of vulnerability, and it creates at least four distinct kinds of risk.

First, structural incompleteness. Because neoteny delays or softens developmental programmes, some structures never fully specialise. The human jaw is smaller than that of our ancestors, which is why wisdom teeth so often fail to erupt and why dental crowding is common. The human spine, built on a quadrupedal blueprint and then reoriented for bipedalism, is prone to lower-back pain and disc herniation. The human foot, with its arch and shortened toes, is a compromise between grasping and walking that leaves us prone to plantar fasciitis and stress fractures. Each of these is a neotenous compromise: a structure that was relaxed from its ancestral form and never fully rebuilt.

Second, airway and swallowing risk. The descended human larynx is one of the most consequential neotenous traits. It enables the complex speech that underwrites language, but it also places the airway and the oesophagus in close proximity, making humans uniquely susceptible to choking and aspiration. In infants, whose larynx is still relatively high, this risk is lower; in adults, whose larynx has descended further, it is higher. A respiratory virus that inflames the airway or impairs swallowing can exploit this geometry.

Third, immune calibration. The human immune system matures slowly, and its calibration— the setting of thresholds for inflammation, tolerance and autoimmunity—depends on a prolonged childhood of microbial exposure. Neoteny extends the period during which the immune system is learning, which is beneficial for adaptability but also means that there is a longer window during which immune calibration can go wrong. Autoimmune diseases, allergies and chronic inflammatory conditions are, in part, failures of immune calibration, and they are more common in humans than in more rapidly maturing species.

Fourth, connective tissue fragility. Because neoteny shifts the expression windows of structural proteins such as elastin and collagen, the connective tissues of the human body are calibrated to a different timeline than those of other primates. This is not a defect in the ordinary sense, but it does mean that human connective tissue is more susceptible to age-related degradation, mechanical stress and inflammatory damage. Elastin, in particular, is laid down early in life and is barely renewed thereafter; a body that depends on elastin for vascular compliance is a body whose vascular resilience declines with age, and whose response to a vascular disease such as severe COVID-19 may be compromised.

These four threats are not separate from the story of Williams syndrome and chromosome 7; they are the same story told at different scales. Williams syndrome is, in a sense, an extreme and localised version of the connective tissue and developmental timing vulnerabilities that neoteny creates in all humans. The elastin haploinsufficiency of Williams syndrome is a dramatic instance of the elastin dependence that every human body shares. And the COVID-19 pandemic was a natural experiment in how those vulnerabilities perform under stress.

Williams Syndrome: A Window into Chromosome 7

Williams syndrome (WS), also called Williams-Beuren syndrome, is a relatively rare microdeletion disorder, occurring in roughly 1 in 7,500 to 1 in 18,000 live births. It is caused by the loss of a contiguous segment of genetic material—1.5 to 1.8 megabases—from the long arm of chromosome 7, at band 7q11.23. The deleted region, known as the Williams-Beuren syndrome critical region (WBSCR), contains 25 to 27 genes. The deletion is almost always de novo, arising from mispairing of low-copy repetitive elements during meiosis, and it is transmitted in an autosomal dominant pattern when an affected parent is involved.

The phenotype is multisystem and distinctive. Cardiovascular disease is cardinal, most characteristically supravalvular aortic stenosis and peripheral pulmonary stenosis, along with a generalised arteriopathy. Connective tissue abnormalities—joint laxity, soft lax skin, hernias, bladder diverticula—are common. Growth is often impaired, with short stature and feeding difficulties in infancy. Endocrine problems include hypercalcaemia in infancy, hypothyroidism and a tendency to diabetes in adulthood. There is mild to moderate intellectual disability, a characteristic cognitive profile with relative strengths in language and music and weaknesses in visuospatial construction, and a striking personality profile of hypersociability, empathy and anxiety.

The craniofacial gestalt is what most people notice first, and it is where the link to neoteny becomes suggestive. Young children with Williams syndrome have a broad forehead, bitemporal narrowing, periorbital fullness, full cheeks, a short nose with an upturned tip, a long philtrum, thick lips, a wide mouth and a small jaw. In older children and adults the face elongates and becomes more gaunt, with a long neck accentuated by sloping shoulders. The childhood face has often been described as "elfin" or "pixie-like"—a set of features that, read through the lens of neoteny, look like an exaggeration of the very juvenile traits that define the human face: large eyes, small nose, full cheeks, small jaw. Whether this resemblance reflects a genuine developmental delay in craniofacial maturation—a kind of localised neoteny—or merely a coincidental facial gestalt is not settled. But the overlap is striking enough that several authors have noted it, and it frames Williams syndrome as, among other things, a disorder of developmental timing.

Genotype-phenotype evidence is strongest for two groups of genes. The ELN gene, encoding elastin, accounts for the vascular and connective tissue features: elastin is the protein that gives arteries, skin and lungs their ability to stretch and recoil, and losing one copy produces the characteristic arteriopathy. The transcription factor genes GTF2I and GTF2IRD1 are strongly implicated in the cognitive, social and anxiety phenotype. Other genes in the region—LIMK1, CLIP2, NCF1 and others—contribute to visuospatial deficits, behavioural regulation and blood pressure. The deletion is therefore not a single-gene disease but a contiguous-gene syndrome, and its breadth is part of why it touches so many systems.

Chromosome 7: More Than a Deletion

Chromosome 7 is a medium-sized autosome, carrying roughly 159 million base pairs and an estimated 900 to 1,100 protein-coding genes. It is not the largest chromosome, but it is unusually rich in genes relevant to development, immunity and connective tissue—the very systems that COVID-19 stresses hardest.

The 7q11.23 region deleted in Williams syndrome is only one of several clinically important loci on the chromosome. The short arm carries genes involved in cystic fibrosis (CFTR, at 7q31.2), certain leukaemias and myelodysplastic syndromes, and immune signalling. The long arm contains genes for drug metabolism, growth factors and—critically for this discussion—components of the extracellular matrix and the immune response.

ELN, the elastin gene, sits at the heart of the Williams deletion. Elastin is not merely a structural protein; it is a signalling molecule. Elastin-derived peptides, generated by the degradation of elastic fibres, act as matrikines—bioactive fragments that influence cell migration, proliferation and inflammation. In the lung, elastin maintains alveolar architecture. In blood vessels, it buffers the pulsatile stress of cardiac output. In skin and connective tissue, it underwrites elasticity. A body with half the normal elastin dosage, as in Williams syndrome, is a body whose elastic tissues are chronically stressed and whose vascular remodelling is abnormal.

Other genes in and around the Williams region matter too. NCF1 encodes a subunit of NADPH oxidase, the enzyme complex that generates reactive oxygen species in phagocytes as part of the innate immune response. Whether NCF1 is included in an individual's deletion modulates hypertension risk in Williams syndrome, and it is a plausible contributor to immune competence. GTF2I and GTF2IRD1 are general transcription factors that regulate the expression of many downstream genes, including some involved in T-cell signalling and social cognition. LIMK1 participates in actin cytoskeleton dynamics, which immune cells rely on for migration and phagocytosis.

Beyond the Williams region, chromosome 7 harbours genes such as IL6 (interleukin-6, a central inflammatory cytokine, at 7p15.3), TNF (tumour necrosis factor, at 6p21.3 actually, but chromosome 7 has related signalling components), and various interferon-related loci. The chromosome also carries the CFTR gene, whose product regulates ion transport in epithelia and whose dysfunction alters airway surface liquid and mucociliary clearance—processes directly relevant to respiratory viral infection.

The point is that chromosome 7 is not an inert address. It is a neighbourhood dense with genes whose products determine how elastic our tissues are, how vigorously our immune system responds, and how our airways handle pathogens. A deletion of 1.5 to 1.8 megabases within it, as in Williams syndrome, is a natural experiment in what happens when that neighbourhood is thinned.

COVID-19: What the Virus Selected For

COVID-19 is caused by SARS-CoV-2, a positive-sense RNA virus whose entry into human cells depends on the ACE2 receptor and the TMPRSS2 protease. From the outset, the disease was strikingly heterogeneous: most infections were mild or asymptomatic, but a minority progressed to severe pneumonia, acute respiratory distress syndrome (ARDS), thrombosis, multi-organ failure and death. Age, sex, obesity, diabetes and cardiovascular disease were the strongest predictors of severity, but they did not explain everything. Host genetics clearly mattered, and genome-wide association studies (GWAS) have now identified dozens of loci associated with susceptibility and severity.

The best-known severe-COVID locus is 3p21.31, near LZTFL1 and SLC6A20, which is associated with respiratory failure. The ABO blood group locus on chromosome 9 modulates infection susceptibility. Interferon pathway genes (IFNAR2, TYK2, OAS1) affect antiviral defence. HLA variation shapes adaptive immunity. And in the largest meta-analyses, a locus on chromosome 7 has repeatedly appeared—sometimes reaching genome-wide significance, sometimes not, and sometimes flagged for missingness across studies. The chromosome 7 signal has been associated with genes such as PRKAR2B, COG5, HBP1 and PIK3CG in sex-stratified analyses, with effects driven in part by males. Whether this signal reflects a genuine, robust association or a statistical shadow of study heterogeneity remains an open question.

What is not in doubt is the biology that COVID-19 attacks. Severe COVID-19 is, in large part, a disease of three systems: the respiratory epithelium and its mucociliary clearance; the vascular endothelium and its elasticity; and the immune system, whose overreaction—cytokine storm, thrombo-inflammation—kills more patients than the virus itself. Elastin deficiency, as in Williams syndrome, compromises vascular compliance and lung recoil. NADPH oxidase dysfunction alters reactive oxygen species production, which both fights infection and drives tissue damage. Transcription factor haploinsufficiency can blunt or dysregulate immune gene expression. And the connective tissue abnormalities of Williams syndrome—lax joints, soft skin, diverticula—hint at a body whose extracellular matrix is already operating outside normal parameters.

There is also the question of social behaviour. Williams syndrome is defined in part by hypersociability: individuals with WS are unusually friendly, approachable and eager to interact with strangers. In a pandemic driven by respiratory transmission, a behavioural phenotype of indiscriminate social approach is a liability. This is not a genetic susceptibility in the immunological sense, but it is a real pathway by which a syndrome can modulate infection risk.

Where the Threads Meet—and Where They Do Not

It is tempting to weave these threads into a single story: neoteny relaxes developmental constraints; Williams syndrome relaxes them further in a specific chromosomal neighbourhood; chromosome 7 carries genes for elasticity and immunity; COVID-19 kills by attacking elasticity and immunity; therefore the four are connected. The temptation should be resisted, or at least heavily qualified.

The solid connections are these. First, neoteny is a real and major feature of human development, and it genuinely leaves us with vulnerabilities—small jaws, descended larynxes, slowly maturing immune systems—that shape disease susceptibility. Second, Williams syndrome is a well-defined contiguous-gene deletion on 7q11.23, with established effects on elastin, transcription and NADPH oxidase, and therefore on vascular, connective and immune function. Third, chromosome 7 carries genes whose products are plausibly relevant to COVID-19 pathophysiology, and GWAS has repeatedly pointed at the chromosome, even if no single robust, replicated signal has emerged from the Williams region itself. Fourth, COVID-19 selects on vascular elasticity, airway clearance and immune regulation—exactly the domains that chromosome 7 genes influence.

The speculative connections are these. There is no evidence that people with Williams syndrome had systematically worse (or better) COVID-19 outcomes than the general population; the syndrome is rare enough that such data are sparse, and its cardiovascular and connective tissue burden would predict worse outcomes while its hypersociability would predict higher exposure. There is no established link between neoteny as an evolutionary process and COVID-19 severity in modern humans; neoteny operates on developmental timescales of millions of years, while the pandemic operated on months. And there is no demonstrated molecular pathway running from neotenous gene regulation through the Williams deletion to SARS-CoV-2 pathogenesis.

The unknowns are substantial. We do not know whether the chromosome 7 GWAS signal will replicate and resolve to a specific gene. We do not know how elastin haploinsufficiency, as in Williams syndrome, interacts with the endothelial dysfunction that characterises severe COVID-19. We do not know whether transcription factors in the Williams region regulate ACE2 expression or interferon responses. And we do not know whether the facial neoteny of Williams syndrome is developmentally meaningful or merely descriptive.

Evolutionary Echo: Why Neoteny Still Matters for Infection

It is worth pausing on why an evolutionary concept like neoteny deserves space in an article about a pandemic. The reason is that evolution does not design bodies from scratch; it tinkers with developmental timing, and the resulting bodies carry the marks of that tinkering into every encounter with a new pathogen. Human neoteny gave us large brains, flat faces and social cognition, but it also gave us airways, jaws and immune systems that are, in important respects, compromises. When SARS-CoV-2 arrived, it did not encounter a species optimised for respiratory viral defence; it encountered a species whose airway anatomy, immune calibration and social behaviour are all products of a developmental process that was still, in evolutionary terms, unfinished.

This is not a claim that neoteny made COVID-19 worse, or that more neotenous individuals fare differently. It is a claim about framing. Medical genetics often treats the body as a machine with parts that can be individually repaired or replaced. Evolutionary developmental biology treats it as a process whose parts are coupled through shared timing and shared genes. Williams syndrome is instructive precisely because it shows how coupled the system is: delete 1.5 megabases on chromosome 7 and you do not get one isolated defect; you get a syndrome that spans the heart, the face, the brain, the connective tissue and the personality. That coupling is what neoteny produces, and it is what makes predicting disease outcomes from single genes so difficult.

The COVID-19 pandemic reinforced this lesson. The 3p21.31 locus, the strongest genetic signal for severe disease, contains not one gene but several, and the causal variant is still debated. The chromosome 7 signal is even less resolved. In both cases, the genetics points not to a single broken part but to a neighbourhood of genes whose joint function determines outcome. That is the logic of developmental systems, and it is the logic that neoteny, Williams syndrome and chromosome 7 all embody.

Conclusion

Neoteny, Williams syndrome, chromosome 7 and COVID-19 are not four names for the same thing. They are four different lenses on a single underlying reality: that human biology is a developmental system, shaped by evolution, encoded in chromosomes, and tested by pathogens. Neoteny explains why our bodies are built the way they are—slowly, flexibly, and with compromises. Williams syndrome shows what happens when a small part of that construction is deleted. Chromosome 7 is where several of the most load-bearing genes live. And COVID-19 was the stress test that revealed, with brutal clarity, which parts of the system could bend and which could break.

The honest conclusion is not a grand unifying theory but a research agenda. We need better data on COVID-19 outcomes in rare genetic syndromes, including Williams syndrome. We need finer-resolution genetic studies of chromosome 7 in severe COVID-19, with sex-stratified and ancestry-aware analyses. We need mechanistic work on how elastin, NADPH oxidase and the Williams transcription factors interact with SARS-CoV-2 infection and the host response. And we need to keep in mind that the human body is not a machine that was finished and then broken by a virus; it is a process that is always, in some sense, still becoming—and that some of its most important features exist precisely because development never quite finished.

References and Further Reading

  • Pober, B. R. (2010). "Williams-Beuren syndrome." New England Journal of Medicine, 362(3), 239–252.
  • Kozel, B. A., et al. (2021). "Williams syndrome." Nature Reviews Disease Primers, 7, 42.
  • Morris, C. A. (2023). "Williams syndrome." GeneReviews.
  • MedlinePlus Genetics. "Chromosome 7" and "Williams syndrome."
  • COVID-19 Host Genetics Initiative. (2021–2023). Meta-analyses of COVID-19 susceptibility and severity. Nature.
  • Wikipedia. "Neoteny" and "Neoteny in humans."
  • Lorenz, K. (1943). "Die angeborenen Formen möglicher Erfahrung." Zeitschrift für Tierpsychologie.

---

This article is an overview for general readers. It is not medical advice, and the connections discussed range from well-established to speculative. Readers with Williams syndrome, or caring for someone who has it, should consult their clinical genetics team for individualised guidance.

Share Telegram X Facebook

Comments (0)

Only goyim slaves with account can comment.